Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 785-789

  Zhu, Bin ^a   Shi, Song ^a   Ma, You Gang ^a   Fan, Fei ^a   Yao, Zhen Zhen ^b  

^a EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Human hepatocellular carcinoma; Invasion; Lysophosphatidic acid; Migration; p38 mitogen activated protein kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GELATINASE A; GELATINASE B; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER NEOPLASMS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84860520457     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11427     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156. (Pubitemid 32911406)
2. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003; 362:1907-1917. (Pubitemid 37518510)
3. Moolenaar WH: Development of our current understanding of bioactive lysophospholipids. Ann N Y Acad Sci 2000; 905:1-10.
4. Toews ML, Ustinova EE, Schultz HD: Lysophosphatidic acid enhances contractility of isolated airway smooth muscle. J Appl Physiol 1997; 83:1216-1222. (Pubitemid 27433090)
5. Mori M, Tsushima H: Activation of Rho signaling contributes to lysophosphatidic acid-induced contraction of intact ileal smooth muscle of guinea-pig. Can J Physiol Pharmacol 2000; 78:729-736.
6. Jalink K, Eichholtz T, Postma FR, van Corven EJ, Moolenaar WH: Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth Differ 1993; 4:247-255.
7. Tigyi G, Fischer DJ, Sebok A, Yang C, Dyer DL, Miledi R: Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho. J Neurochem 1996; 66:537-548.
8. Moolenaar WH, van Meeteren LA, Giepmans BN: The ins and outs of lysophosphatidic acid signaling. Bioessays 2004; 26:870-881. (Pubitemid 39128101)
9. Anliker B, Chun J: Lysophospholipid G protein-coupled receptors. J Biol Chem 2004; 279:20555-20558. (Pubitemid 38656446)
10. Mills GB, Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003; 3:582-591. (Pubitemid 37328830)
11. Wang DS, Dou KF, Li KZ, Song ZS: Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway. World J Gastroenterol 2004; 10:299-302.
12. Sun H, Ren J, Zhu Q, Kong FZ, Wu L, Pan BR: Effects of lysophosphatidic acid on human colon cancer cells and its mechanisms of action. World J Gastroenterol 2009; 15:4547-4555.
13. Folkman J: A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression. J Natl Cancer Inst 2001; 93:734-735.
14. Xu X, Prestwich GD: Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer 2010; 116:1739-1750.
15. Li X, Lv Y, Yuan A, Yi S, Ma Y, Li Z: Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation. Oncol Rep 2010; 24:441-448.
16. Yang F, Yin Y, Wang F, Wang Y, Zhang L, Tang Y, Sun S: miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 2010; 51:1614-1623.
17. Raskopf E, Vogt A, Standop J, Sauerbruch T, Schmitz V: Inhibition of Neuropilin-1 by RNA-Interference and its Angiostatic Potential in the Treatment of Hepatocellular Carcinoma. Zeitschrift Fur Gastroenterologie 2010; 48:21-27.
18. Guo K, Liu Y, Zhou H, Dai Z, Zhang J, Sun R, Chen J, et al.: Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion. Cancer Sci 2008; 99:486-496. (Pubitemid 351228564)
19. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY: p38 mitogen-activated protein kinase pathway is involved in protein kinase C alpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 2007; 67:4320-4327.
20. Nakanishi H, Yoshioka K, Joyama S, et al.: Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Am J Pathol 2004; 165:471-480. (Pubitemid 38971377)
21. Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD: Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer 2010; 116:2768-2782.
22. Qin LX, Tang ZY: The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8:385-392.
23. Bartsch JE, Staren ED, Appert HE: Adhesion and migration of extracellular matrix-stimulated breast cancer. J Surg Res 2003; 110:287-294. (Pubitemid 36403720)
24. Hosch SB, Steffani KD, Scheunemann P, Izbicki JR: Micrometastases from HBP malignancies and metastatic cancer. J Hepatobiliary Pancreat Surg 2002; 9:583-591. (Pubitemid 36305104)
25. Jiang YF, Yang ZH, Hu JQ: Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 2000; 6:61-65. (Pubitemid 30093064)
26. Lee J, Park SY, Lee EK, Park CG, Chung HC, Rha SY, Kim YK, et al.: Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin Cancer Res 2006; 12:6351-6358. (Pubitemid 44799704)
27. Chung TW, Lee YC, Kim CH: Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. Faseb J 2004; 18:1123-1125. (Pubitemid 39561544)
28. Simon C, Goepfert H, Boyd D: Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 1998; 58:1135-1139. (Pubitemid 28183199)